Francesca Montanari - Concepedia

Author

Francesca Montanari

Istituti di Ricovero e Cura a Carattere Scientifico ORCID

Also Known As

F M Montanari, F Montanari, F. Montanari, F.M. Montanari, Francesca Montanari, Tommaso Pippucci

100

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

Istituti di Ricovero e Cura a Carattere Scientifico University of Pavia Columbia University Irving Medical Center University of Bologna Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda

About

Francesca Montanari is an author at Istituti di Ricovero e Cura a Carattere Scientifico specializing in medicine, immunology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	12	500
2	Blood Transplantation	3	3	49
3	Health Sciences	2	2	33
4	Cell Biology	1	1	23
5	Cellular Therapies	1	1	10

Francesca Montanari

Publications

Citations

H-Index

Page 1

	Year	Citations
Combined oral 5-azacytidine and romidepsin are highly effective in patients with PTCL: a multicenter phase 2 study Lorenzo Falchi, Helen Ma, Sandra E. Klein, Blood	2020	174
Prevalence of HCV infection in nongastric marginal zone B-cell lymphoma of MALT Luca Arcaini, S. Burcheri, Andrea Rossi, Annals of Oncology Lymphoid NeoplasiaHcv InfectionViral HepatitisImmunologyHepatitis	2006	145
Oral 5-azacytidine and romidepsin exhibit marked activity in patients with PTCL: a multicenter phase 1 study Owen A. O’Connor, Lorenzo Falchi, Jennifer Kimberly Lue, Blood	2019	127
Primary nodal marginal zone B‐cell lymphoma: clinical features and prognostic assessment of a rare disease Luca Arcaini, Marco Paulli, Sara Burcheri, British Journal of Haematology Prognostic AssessmentLymphoid NeoplasiaHepatologyRare DiseaseMedicine	2006	77
Nongastric Marginal-Zone B-Cell MALT Lymphoma: Prognostic Value of Disease Dissemination Luca Arcaini, Sara Burcheri, Andrea Rossi, The Oncologist Hematological MalignancyLymphoid NeoplasiaMedicineBone Marrow InvolvementSurgical Pathology	2006	67
A restricted spectrum of missense KMT2D variants cause a multiple malformations disorder distinct fromKabuki syndrome Sara Cuvertino, Verity Hartill, Alice Colyer, Genetics in Medicine	2020	64
Response to long‐term growth hormone therapy in patients affected by RASopathies and growth hormone deficiency: Patterns of growth, puberty and final height data Federica Tamburrino, Dino Gibertoni, Cesare Rossi, American Journal of Medical Genetics Part A	2015	41
Immunochemotherapy with in vivo purging and autotransplant induces long clinical and molecular remission in advanced relapsed and refractory follicular lymphoma Luca Arcaini, Francesca Montanari, Emilio Paolo Alessandrino, Annals of Oncology Lymphoid NeoplasiaAutoimmune DiseaseMolecular RemissionMedicineMalignant Blood Disorder	2008	41
Bortezomib-Induced Tumor Lysis Syndrome in a Patient With HIV-Negative Plasmablastic Lymphoma Mark Lipstein, Owen O’Connor, Francesca Montanari, Clinical Lymphoma Myeloma & Leukemia Lymphoid NeoplasiaHiv-negative Plasmablastic LymphomaHematologyImmunologyPathology	2010	35
A Phase II Trial of Chloroquine in Combination with Bortezomib and Cyclophosphamide in Patients with Relapsed and Refractory Multiple Myeloma Francesca Montanari, Meina Lu, Sara Rani Marcus, Blood	2014	29

Page 1